Ubs Group Ag Valneva Se Transaction History
Ubs Group Ag
- $555 Billion
- Q2 2025
A detailed history of Ubs Group Ag transactions in Valneva Se stock. As of the latest transaction made, Ubs Group Ag holds 1 shares of VALN stock, worth $8. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1
Previous 37
97.3%
Holding current value
$8
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding VALN
# of Institutions
20Shares Held
4.52MCall Options Held
0Put Options Held
0-
Novo Holdings Hellerup, G72.38MShares$21 Million1.17% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA1.46MShares$12.9 Million0.44% of portfolio
-
General American Investors CO Inc354KShares$3.14 Million0.14% of portfolio
-
Wells Fargo & Company San Francisco, CA245KShares$2.17 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il35.7KShares$316,2810.0% of portfolio
About Valneva SE
- Ticker VALN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,103,504
- Market Cap $612M
- Description
- Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; ...